Introduction
============

RNA interference (RNAi) is a functional conserved process that regulating gene expression at the post-transcriptional level [@B1]. It is triggered by 21-23 nucleotides small interfering RNAs (siRNAs) which is phosphorylated at the 5\' terminal and hydroxylated at the 3\' terminal [@B2], [@B3]. The process of RNAi can be divided into two major steps: the initiation step and the effector step [@B4]. In the initial step, introduced long dsRNA or short-hairpin RNA (shRNA) are digested into siRNA by Dicer, an RNA-III family exonuclease [@B5]. In the subsequent effector step, the siRNA unwound and incorporated into the functional protein complex: RNA-induced silencing complex (RISC), guiding Argonaute (Ago) to degrade the target mRNA and disrupting target gene transcription [@B6]. In addition to Dicer and Ago, numerous affiliated factors, including R2D2 [@B7]-[@B9], transactivation region RNA binding protein (TRBP) [@B10], heat-shock protein 90 (HSP90) [@B11] and systemic RNA interference-deficient (SID) [@B12], play important roles in the RNAi machinery of many organisms.

Sequence-specific RNAi has been extensively applied in the functional analysis of insect genes and in pest management [@B13]. However, RNAi efficiency is highly variable between different insect species and even between different tissues and developmental stages within the same insect species. In the coleopteran insect *Tribolium castaneum* and the orthopteran insect *Locusta migratoria*, a robust systemic RNAi response can be induced by the direct injection of dsRNA into the hemocoel [@B14]-[@B18]. There has been little success with the direct injection of dsRNA into the body cavity of the model insect *Drosophila melanogaster*[@B19]; however, transgenic RNAi approaches have been well established to drive dsRNA or shRNA to silence target genes*in vivo*[@B20], [@B21]. Different tissues in the same species also show diverse RNAi responses. For example, introduced dsRNA is effective for most tissues in *Anopheles gambiae*and *Caenorhabditis elegans*, but the central nervous system displays a refractory RNAi response [@B22], [@B23]. In the lepidopteran insect *Manduca sexta,* genes expressed in immune cells are sensitive to RNA silencing, while those expressed in the epidermal tissue are rather refractory [@B24]. Thus, exploring the critical RNAi factors in insects is urgently needed to develop RNAi as a comprehensive tool for functional gene analysis, especially in non-drosophilid species.

The silkworm, *Bombyx mori*, is a lepidopteran model insect with economic importance. dsRNA- or shRNA-mediated RNAi has been effective in several *B. mori* cell lines and embryos [@B25]-[@B29]. However, little success has been reported for RNAi in *B. mori* larvae, although wandering stage larvae showed sensitivity to large amounts of dsRNA injection [@B30], [@B31]. Screening for genes in the RNAi pathway revealed that most of the conserved RNAi factors are present in *B. mori*, except two dsRNA-binding proteins, BmR2D2 and BmTranslin, show minimal expression levels [@B32]. shRNA-mediated RNAi was enhanced by introducing *Escherichia coli* RNase III into a silkworm cell line [@B33]. Furthermore, introduction of the *C. elegans SID-1* gene, which is responsible for dsRNA transportation, into BmN cells enhanced the uptake of dsRNA [@B26], [@B34]. However, no significant silencing enhancement was observed when *CeSID-1* was ectopically over-expressed in silkworms [@B26], [@B34]. Although numerous studies have been carried out to explore the factors that limit RNAi in *B. mori*, no endogenous RNAi enhancers have been identified [@B35].

Four Argonaute proteins, BmAgo1, BmAgo2, BmAgo3 and BmPIWI, have been identified in *B. mori*[@B36]. BmAgo1 and BmAgo2 are included in the Ago subfamily, which are responsible for siRNA- and miRNA-mediated post-transcriptional silencing, respectively [@B37]. However, BmAgo3 and BmPIWI are described as the PIWI subfamily members and express in the silkworm gonads significantly [@B38]. Our results demonstrate that BmAgo2, rather than the other silkworm Ago proteins, binds to siRNA, indicating that *BmAgo2* functions as the core RNAi machinery in *B. mori*. Disruption of *BmAgo2* by introducing *BmAgo2*-specific dsRNA inhibited the RNAi response in both BmN cultured cells and embryos. Furthermore, transgenic over-expression of *BmAgo2* significantly facilitated both dsRNA- and shRNA-mediated larval RNAi in *B. mori*. In conclusion, our results demonstrate that over-expression of *BmAgo2* improves RNAi efficiency in *B. mori,*particularly during the larval feeding stages.

Materials and Methods
=====================

Insect strains and cell lines
-----------------------------

The silkworm strain, Nistari, was used for the germline transformations and other experiments. A bivoltine strain, Dazao, was used for embryonic RNAi experiments. Silkworm larvae were fed with mulberry leaves at 25°C [@B39].

The silkworm ovary-derived BmN cell line was cultured with Tc100 insect medium containing 10% fetal bovine serum (Gibco) at 27°C.

Electrophoretic mobility shift assays (EMSA) and MALDI-TOF/TOF analysis
-----------------------------------------------------------------------

Crude embryonic protein extracts were prepared as previously described [@B40]. Double-stranded oligonucleotides targeting the 5\'-GCAGCACGACUUCUUCAAG-3\' sequence of *enhanced green fluorescence Protein*(*EGFP*) were synthesized with FAM labeling at the 3\' ends via an LC-LC linkage (RiboBio). The reaction mixture containing 5 μg extracted crude protein and 2 μl (10 mg/ml) labeled *EGFP* siRNA probe were incubated for 30 min at 37°C using the Thermo Scientific LightShift Chemiluminescent RNA EMSA Kit (Thermo). Subsequently, the reaction mixture was subjected to electrophoresis using a 6% native polyacrylamide gel at 100 V for 2 h, and the gel was photographed with a FUJIFILM FLA-9000 image reader (Fujifilm).

After photographing, the EMSA gel was stained with R-250 Coomassie Brilliant Blue (CBB), and the protein band whose position was shifted by the siRNA probe was excised. The excised gel bands were washed with ultrapure water three times, destained with 20 mM NH~4~HCO~3~ dissolved in 50% acetonitrile. Subsequently, the sample was dried with 100% acetonitrile and digested by trypsin (Promega) overnight at 37°C. The pooled and lyophilized peptides dissolved in 5 mg/mL CHCA with 0.1% TFA and 50% acetonitrile were sent for MALDI-TOF/TOF analysis subsequently.

Plasmid preparation
-------------------

The promoter sequences in the *phRL-TK*and *pGL3*plasmids (Promega) were replaced by the silkworm baculovirus immediate-early gene promoter IE1 (*pIE1-RL* and *pIE1-GL*) and used for the dual luciferase reporter assay in the BmN cell line [@B41]. The 5\'-GTGCTCGTAGGAGTAGTGAAA-3\' sequence of *Renilla luciferase* (*RL*) was used to design shRNA and was amplified with the primers (RL shRNA) listed in [Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S1, as previously reported by Tanaka et al. [@B42].

Three transformation plasmids were constructed based on the initial *piggyBac* vectors *pBac\[3xp3-DsRed\]* and *pBac\[3xp3-EGFP\]*: *pBac\[IE1-DsRed\]* (*IE1-DsRed*), *pBac\[IE1-DsRed-OpIE2-BmAgo2\]* (*OpIE2-BmAgo2*) and *pBac\[3xp3-EGFP-U6-Blos2 shRNA\]* (*U6-Blos2 shRNA*) [@B43].

The 3xp3 promoter in the *pBac\[3xp3-DsRed\]* plasmid was replaced with the IE1 promoter to generate the *IE1-DsRed*plasmid using ClonExpress^TM^ II One Step Cloning Kit (Vazyme Biotech Co., Ltd.) [@B43]*.*The open reading frame (ORF) of *BmAgo2* was amplified from silkworm embryonic cDNA according to the sequence deposited in GenBank (NM_001043530.2). To strongly induce the expression of *BmAgo2*, the 3116-bp *BmAgo2* ORF was inserted into the *pIZT/V5-His A*plasmid (Invitrogen) downstream of the optimized silkworm baculovirus immediate-early gene promoter IE2 (OpIE2). Subsequently, the OpIE2-Ago2-SV40 cassette was sub-cloned into the *IE1-DsRed* plasmid via AscI and FseI double digestion to generate the plasmid *OpIE2-BmAgo2*. For the *U6-Blos2 shRNA* plasmid, the 467-bp silkworm small nuclear RNA promoter U6 was amplified from silkworm genomic DNA and used as a template to amplify the U6-Blos2 shRNA cassette using a primer pair BmBlos2 shRNA that contained the shRNA target in the reverse primer (Table S1). *BmBlos2*shRNA targeting the sequence 5\'-TCAAGCAGCATGTAGTGTTCC-3\' was designed using the Invitrogen BLOCK-iT^TM^RNAi Designer (<http://rnaidesigner.lifetechnologies.com/rnaiexpress/>). The sequenced U6-Blos2 shRNA cassette was sub-cloned into the *pBac\[3xp3-EGFP\]* plasmid, which contains the selection marker *EGFP* gene driven by eye-specific promoter 3xp3, to generate the *U6-Blos2 shRNA* plasmid.

Double-stranded RNA (dsRNA) preparation and treatment
-----------------------------------------------------

The following gene-specific sequences were used as the dsRNA templates: a 449-bp fragment targeting *Renilla Luciferase*(*RL*), a 504-bp fragment targeting *BmAgo2*, a 367-bp fragment targeting *EGFP* and a 416-bp fragment targeting *DsRed*. dsRNA was synthesized using the T7-MEGAScript kit (Ambion) with the primers listed in Table S1. We incubate the reaction mixture at 37°C for 3 h, heat shocked it at 75°C for 5 min and annealed the double strands at room temperature for 1 h. Subsequently, dsRNA were treated with DNase I to remove the templates and purified with phenol/chloroform.

Purified dsRNA was dissolved in distilled water and used to transfect the BmN cells using the Effectene Transfection Reagent (Qiagen) according to the manufacturer\'s instructions. Either 0.5 μg/μl or the indicated concentration of dsRNA targeting the silkworm genes *white egg 2*(*Bmw-2*) and *BmAgo2* was injected into preblastoderm embryos. For larval RNAi, 10 μg/larvae (5 μg/μl) of *DsRed*or*EGFP* dsRNA was injected into transgenic silkworms on day one of the third larval instar. All the subjected animals expressed comparable fluorescence levels and were staged at the third instar ecdysis. After injection, the animals were reared separately, and the fluorescence was observed via fluorescence microscopy (Nikon AZ100).

Quantitative real-time PCR (qRT-PCR)
------------------------------------

TRIzol Reagent purchased from Invitrogen was used to extract the total RNA. Subsequently, the RNA was treated with DNase I (Takara) to remove the genome DNA. One microgram of extracted RNA was used as the templates to synthesize cDNA using the RevertAid First-Strand cDNA synthesis kit (Fermentas). Quantitative mRNA measurements were performed with TOYOBO SYBR Green Realtime PCR Master Mix. Three independent biological replicates were examined by Eppendorf Mastercycler ep realplex. The PCR program was the following: incubation at 94°C for 3 min, followed by 40 cycles of 94°C for 10 s and 55°C for 20 s. The standard curves were performed with 10-fold serial dilution cDNA. The data were normalized to *B. mori ribosomal protein 49* (*Bmrp49*) and analyzed by GraphPad Prism version 5.01. All of the qRT-PCR primers are included in Table S1.

Dual luciferase assays
----------------------

The *pIE1-RL* plasmid, which expresses *RL*, was used as a reporter to indicate RNAi efficiency, and the*pIE1-GL* plasmid containing the *Firefly Luciferase*(*FL*) reporter gene was used as a control to indicate the transfection efficiency. The relative luciferase activity was calculated by normalizing *RL* to *FL*(RL/FL).

BmN cells were placed in 96-well plates (Nunc), and the medium was replaced after 24 hours (150 μl). The cells were subsequently transfected with *BmAgo2*dsRNA (20 ng/well, 24 h later) and later co-transfected with the luciferase plasmids (25 ng/well for *pIE1-GL* and 100 ng/well for *pIE1-RL*, 72 h later). *RL*dsRNA was co-transfected along with the *pIE1-RL*and*pIE1-GL*plasmids at 5 ng/well during the second transfection to determine dsRNA-mediated RNAi efficiency. The shRNA-mediated RNAi efficiency was determined by co-transfecting the *U6-RL shRNA* plasmid with two luciferase expression plasmids.

Germline transformation and inverse PCR
---------------------------------------

Plasmid transformations were performed by microinjection into the preblastoderm G~0~embryos followed by incubation at 25°C in a humidified chamber before hatching [@B43]. The resulting G~0~ adults were inbred, and the G~1~ embryos were screened for the expression of the fluorescence protein using a Nikon AZ100 fluorescence microscope.

Silkworm genomic DNA was extracted with the UniversalGen DNA Kit (CWBio) from the G~1~ transgenic moths. The genomic DNA was then digested with DpnII and ligated at 4°C overnight. Primers listed in Table S1 were used for amplification, and PCR was performed using the following conditions: 94°C for 2 min, followed by 40 cycles of 94°C for 15 s, 55°C for 15 s, and 72°C for 1 min, followed by a final extension period of 72°C for 10 min. The purified PCR products were cloned into the pMD18-T vector and sequenced directly.

Western blots
-------------

The entire body of G~1~fifth instar larva was homogenized and dissolved in PBS (phosphate-buffered saline). The protein concentration was quantified with Pierce^TM^BCA Protein Assay Kit (Thermo). Samples were separated in 8% SDS-PAGE and then transferred to nitrocellulose membranes (GE Healthcare). The monoclonal mouse anti-BmAgo2 (1:500 dilution; Abmart) and anti-α-tubulin (1:1000 dilution; Vazyme Biotech Co., Ltd.) primary antibodies were used to detect the BmAgo2 and α-tubulin proteins [@B44], respectively. The secondary antibody used here was goat anti-mouse IgG (1:5000 dilution; Beyotime, Shanghai, China) with horseradish peroxidase-conjugated.

Statistics analysis of data
---------------------------

All the data was analyzed using GraphPad Prism (version 5.01) with One-way ANOVA and the Dunnett*post-hoc* test analysis. All error bars are the means ± S.E.M. *p*\<0.05 was used to determine significance in all cases.

Results and Discussion
======================

*BmAgo2*is one of the core RNAi factors in *B. mori*
----------------------------------------------------

RNA EMSA and MALDI-TOF/TOF were used to screen siRNA-interacting proteins in *B. mori* embryos. Seven proteins, including the heat shock proteins HSP70 and HSP70B, Cellular Retinoic Acid Binding Acid (CRABA) protein and Enolase, were identified with significant abundance (Table [1](#T1){ref-type="table"}). The number of matched peptides for these four detected proteins was 8, 2, 2 and 4, respectively (Table [1](#T1){ref-type="table"}). Furthermore, the conserved RNAi components Ago2, Dicer2 and Tudor-sn were also detected in the protein complex with 5, 11 and 8 matched peptides, respectively (Table [1](#T1){ref-type="table"}). For the sequence coverage, we calculated the number of matched amino acids and divided it by the length of each protein. The sequence coverage of the former four proteins was 14.33%, 4.5%, 16.54% and 8.08%, respectively, and the sequence coverage of BmAgo2, BmDicer2 and BmTudor-sn was 4.82%, 7.45% and 9.68%, respectively (Table [1](#T1){ref-type="table"}). Detailed information on the matched peptides was presented in [Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S2, and the peptide spectra were included in [Supplementary Material](#SM1){ref-type="supplementary-material"}: Fig. S1-S7. As Ago2 is one of the conserved components of the RNAi machinery in insects [@B25], we exploited the function of *BmAgo2* in *B. mori* RNAi in the current study.

*BmAgo2* affected the RNAi response in the BmN cell line
--------------------------------------------------------

To explore the role of *BmAgo2* in the *B. mori*RNAi machinery, we constructed several transfection plasmids (Fig. [1](#F1){ref-type="fig"}A, B and C) and performed double RNAi assays ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Fig. S8A) in the BmN cell line to investigate whether depletion of *BmAgo2* affecting the RNAi response. The transcription level of endogenous *BmAgo2* was down-regulated to 60% of the control (no dsRNA or*EGFP* dsRNA) after transfection with dsRNA targeting *BmAgo2* (Fig. [2](#F2){ref-type="fig"}A), suggesting that *BmAgo2*dsRNA-mediated RNAi effect was significant in BmN cells. Subsequently, we investigated effect of *BmAgo2* RNAi on the silencing potency of *Renilla Luciferase* (*RL*) dsRNA or shRNA using dual luciferase reporter assays. Transfection with *RL* dsRNA down-regulated the relative *RL/FL* level to 11% of the level observed in control cells that were not transfected with *RL* dsRNA ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Fig. S9). In comparison, the relative luciferase activity was increased 2.2-fold (22% of the control) by co-transfection of *BmAgo2* dsRNA with *RL* dsRNA (Fig. [2](#F2){ref-type="fig"}B), suggesting that the depletion of *BmAgo2* inhibited the dsRNA-mediated RNAi response in BmN cells. In addition, *RL*shRNA expression directed by the U6 promoter (*U6-RL shRNA,*Fig. [1](#F1){ref-type="fig"}C) down-regulated the RL/FL level to 50% compared to the control (Fig. S9). When *BmAgo2*dsRNA was co-transfected with the *U6-RL shRNA*, the relative RL/FL level recovered to that of the control, indicating that the RNAi effect was completely inhibited (Fig. [2](#F2){ref-type="fig"}C). In conclusion, our results demonstrate that *BmAgo2* is involved in regulating both dsRNA- and shRNA-mediated RNA silencing in BmN cells.

*BmAgo2* affected the RNAi response in embryos
----------------------------------------------

To investigate the role of *BmAgo2* in the RNAi response *in vivo*, we performed embryonic double RNAi (Fig. S8B) targeting the silkworm *white egg 2* (*Bmw-2*) gene, which is responsible for the accumulation of ommochrome pigments in silkworm eggs [@B45], [@B46]. We injected dsRNA targeting *Bmw-2* into preblastoderm embryos of the Dazao strain, as the eggs of this strain become scarlet due to serosa pigmentation 24 h after oviposition. Pigments failed to accumulate in 89% (n=80) of the eggs after *Bmw-2* dsRNA injection (Fig. [3](#F3){ref-type="fig"}A\'\' and B), showing that the RNAi response was effective in embryos, which was consistent with previous results [@B28]. When *BmAgo2* dsRNA (0.5 μg/μl) was co-injected with *Bmw-2*dsRNA, the ratio of white eggs decreased to 60% (n=80), and the remaining eggs were a light scarlet color (Fig. [3](#F3){ref-type="fig"}A\'\'\' and B). Furthermore, the ratio of white eggs decreased in a dose-dependent manner with increasing concentrations of *BmAgo2* dsRNA (45% when treated with 1 μg/μl *BmAgo2* dsRNA, and 28% when treated with 1.5 μg/μl *BmAgo2* dsRNA, Fig. [3](#F3){ref-type="fig"}B). No egg pigmentation defects were observed when dsRNA targeting *EGFP*was co-injected with *Bmw-2* dsRNA as the control (Fig. [3](#F3){ref-type="fig"}A\'). When *BmAgo2* dsRNA was introduced, the *BmAgo2* transcription level was down-regulated to 50% of that in the control (injected with *EGFP* dsRNA) as determined by qRT-PCR (Fig. [3](#F3){ref-type="fig"}C). *Bmw-2* transcription was down-regulated to 10% of the control (injected with *EGFP* dsRNA) when only the *Bmw-2* dsRNA was injected and to 40% of the control after co-injection with the *BmAgo2* and *Bmw-2* dsRNAs (Fig. [3](#F3){ref-type="fig"}D), indicating that introducing *BmAgo2* dsRNA inhibited the *Bmw-2*RNAi efficiency in *B. mori* embryos.

Generation of transgenic silkworm lines
---------------------------------------

To investigate whether *BmAgo2* functions in the *B. mori*RNAi response during the post-embryonic stages, especially the larval stages, we established transgenic silkworm lines that ectopically express *BmAgo2* in a ubiquitous manner driven by the IE2 promoter (*OpIE2-BmAgo2*, Fig. [1](#F1){ref-type="fig"}E). A total of 960 preblastoderm eggs were injected and 333 survived to the adult stage. By inbreeding or crossing with the wild type moths, 56 individual G~1~batches were screened based on red fluorescence and 7 batches had one or more positive transgenic silkworms. The transformation efficiency was accordingly 12.5%. Two independent lines were selected and genomic insertion sites were determined ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Fig. S10A). Significant over-expression of *BmAgo2* was detected and reached a maximum of 124-fold compared to the control animals (*IE1-DsRed*, Fig. [1](#F1){ref-type="fig"}D) in the fifth larval instar (Fig. [4](#F4){ref-type="fig"}). Additionally, a significant increase in the BmAgo2 protein level in the fifth larval instar was confirmed using western blotting analysis (Fig. [4](#F4){ref-type="fig"}).

Two more transgenic silkworm lines, *IE1-DsRed* (Fig. [1](#F1){ref-type="fig"}D) and *U6-Blos2 shRNA*(Fig. [1](#F1){ref-type="fig"}F), were also constructed with transformation efficiency of 7.6% and 8.5% separately. Three independent lines were created for each transgene, and all of the insertion sites were in non-functional sequences of the silkworm genome (Fig. S10). No deleterious phenotypes were observed during the growth and development of these transgenic silkworm lines and we chose one line for each transgene to use in the subsequent experiments.

Over-expression of *BmAgo2*enhanced dsRNA-mediated RNAi
-------------------------------------------------------

The IE1-directed *DsRed* gene was also introduced as a reporter gene and a selection marker. dsRNA was injected into the hemocoel of *BmAgo2* transgenic animals to examine the larval RNAi efficiency. 72% (n=25, Table [2](#T2){ref-type="table"}) of the *OpIE2-BmAgo2* transgenic animals showed significantly decreased red fluorescence (Fig. [5](#F5){ref-type="fig"}B) 24 h after *DsRed*dsRNA injection. A further slight decrease in *DsRed* fluorescence was observed 48 h after injection (Fig. [5](#F5){ref-type="fig"}B, Table [2](#T2){ref-type="table"}). qRT-PCR analysis revealed that dsRNA injection down-regulated the *DsRed* transcription level to 40% of the control (non-injected) after 24 h. Consistent with the fluorescence microscopy analysis, the RNAi efficiency was time-dependent, and the transcription level of *DsRed* was restored to 60% and 77% of the control at 48 h and 72 h after injection, respectively (Fig. [5](#F5){ref-type="fig"}D). No significant decrease in the red fluorescence signal was observed in *OpIE2-BmAgo2* animals without injection or with *EGFP* dsRNA injection (Fig. [5](#F5){ref-type="fig"}B). In the control *IE1-DsRed*animals, no obvious fluorescence decrease was observed either with or without injection with *EGFP* and *DsRed*dsRNA (Fig. [5](#F5){ref-type="fig"}A and Table [2](#T2){ref-type="table"}). The qRT-PCR results revealed that the transcription level of *DsRed* did not change significantly in *IE1-DsRed*animals (Fig. [5](#F5){ref-type="fig"}C). Both fluorescence investigation and qRT-PCR analysis suggest over-expression of *BmAgo2* facilitates dsRNA-mediated RNAi in the larval silkworms.

*BmAgo2*over-expression enhanced shRNA-mediated RNAi
----------------------------------------------------

As shRNA is ultimately processed into mature siRNA to function in mRNA degradation similar to dsRNA, we speculate that *BmAgo2* also plays an important role in the shRNA-mediated RNAi pathway. A transgenic silkworm line that expresses the *BmBlos2* shRNA under the control of the U6 promoter (*U6-Blos2 shRNA*) was used to determine the shRNA-mediated silencing efficiency (Fig. [1](#F1){ref-type="fig"}F) [@B47], [@B48]. *BmBlos2*plays important role in silkworm urate granule synthesis in the silkworm larval epidermis. The mutation of *BmBlos2* results in translucent larval skin, which was designated as the oily skin phenotype (OSP) [@B49]. Expressing *BmBlos2* shRNA in *U6-Blos2 shRNA* transgenic larvae resulted in OSP (Fig. [6](#F6){ref-type="fig"}A). We then crossed the *OpIE2-BmAgo2* and the *U6-Blos2 shRNA* transgenic lines and investigated the frequency of OSP in the offsprings. Of the animals that only expressed the *BmBlos2* shRNA (Blos2^-^), 28.9% (n=97) displayed OSP during the larval stages (Fig. [6](#F6){ref-type="fig"}A and Table [3](#T3){ref-type="table"}). Of the animals that expressed both the *BmAgo2* and *BmBlos2* shRNA (Ago2^+^ Blos2^-^), 64.3% (n=56) showed OSP (Fig. [6](#F6){ref-type="fig"}A and Table [3](#T3){ref-type="table"}). Furthermore, the OSP was more severe in the Ago2^+^Blos2^-^animals than in the Blos2^-^ animals (Fig. [6](#F6){ref-type="fig"}A). We performed qRT-PCR analysis to quantify the RNAi efficiency as enhanced by *BmAgo2* over-expression and showed that the *BmBlos2* transcription level was down-regulated to 75% in Blos2^-^animals compared with their Ago2^+^ siblings (Fig. [6](#F6){ref-type="fig"}B). However, in Ago2^+^Blos2^-^ animals, the *BmBlos2* transcription level was down-regulated to 30% compared to their Ago2^+^ siblings (Fig. [6](#F6){ref-type="fig"}B). The results presented here indicate that over-expression of *BmAgo2* significantly facilitates shRNA-mediated RNAi when targeting *BmBlos2*.

Although numerous factors are involved in the insect RNAi machinery, we have identified *BmAgo2* as one of the important RNAi factors in *B. mori*and provided a promising approach for enhancing RNAi efficiency in *B. mori* larvae. The disruption of *BmAgo2* in BmN cells and embryos reduced the efficiency of RNAi, while the over-expression of *BmAgo2* facilitated the RNAi effect during the larval stages in transgenic animals. Furthermore, *BmAgo2* was shown to be involved in both the dsRNA- and shRNA-mediated RNAi effect both *in vitro* and *in vivo*. Enhancing larval RNAi efficiency by over-expressing *BmAgo2* will greatly contribute to both RNAi-based analysis of gene function and pest management in lepidopteran insects.
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![**Schematics of plasmids used in this study. A-C:** Plasmids for cell transfection; **D-F:** Plasmids for germ line transformation. **A.** *pIE1-RL*; **B.** *pIE1-GL*; **C.** *pIE1-RL-U6-RL shRNA*; **D.** *pBac\[IE1-DsRed\]*; **E.** *pBac\[IE1-DsRed-OpIE2-BmAgo2\]*; and **F.** *pBac\[3xp3-EGFP-U6-Blos2 shRNA\]*. Orange arrows indicate promoters; light-blue arrows indicate *piggyBac* recombination sites; grey boxes indicate polyadenylation transcription terminal sequences; colored boxes indicate coding regions.](ijbsv11p0176g001){#F1}

![**Assessment of *BmAgo2* function in RNAi via dual luciferase reporter assay in BmN cells. A.** Quantification of the endogenous *BmAgo2* transcription level by quantitative real-time PCR (qRT-PCR); **B.** Inhibition of dsRNA-mediated *RL* silencing by disruption of *BmAgo2* transcription; **C.** Complete inhibition of shRNA-mediated *RL* silencing by the disruption of *BmAgo2* transcription. Three independent biological replicates were used for quantification. The relative luciferase activity in B and C were calculated by dividing the *RL* activity by the *FL* activity. The asterisks represent significant difference (*p*\<0.05) between groups. Error bars are the means ± S.E.M.](ijbsv11p0176g002){#F2}

![**Disruption of *BmAgo2* transcription affected the RNAi response in embryos. A\'- A\'\'\'.** Eggs photographed under bright field on day 5 after dsRNA injection. Scale bars represent 0.25 mm. The eggs were injected with *EGFP* dsRNA (A\'), with *Bmw-2* dsRNA (**A\'\')** or with both *BmAgo2*and *Bmw-2*dsRNA (A\'\'\'); **B.**Statistic of the egg color. 80 eggs were injected for each group; **C and D.** qRT-PCR analysis of the level of *BmAgo2* and *Bmw-2* transcription. Three independent biological replicates were analyzed. The asterisks indicate statistical significance (*p*\<0.05), and error bars are means ± S.E.M.](ijbsv11p0176g003){#F3}

![**Over-expression of *BmAgo2* in *pBac\[IE1-DsRed-OpIE2-BmAgo2\]* (*OpIE2-BmAgo2*) transgenic silkworms.** Whole bodies of day one of each instar larvae were homogenized, and the total RNA was extracted. The plasmid that only expressed the selection marker (*IE1-DsRed*) was used as a control. For each stage, three transgenic animals were used to extract the total RNA. Error bars are means ± S.E.M, and the inset shows the increased translation of *BmAgo2*in the final instar larvae.](ijbsv11p0176g004){#F4}

![**DsRNA-mediated larval RNAi was enhanced in*OpIE2-BmAgo2* transgenic silkworms. A and B.** Day one of third instar larvae injected with dsRNA were photographed under UV light equipped with an RFP filter at 0 h, 24 h and 48 h after injection. Non-injected and *EGFP* dsRNA-injected larvae were used as controls, and *DsRed* dsRNA-injected larvae were used as reporters to indicate silencing efficiency. **A.** *IE1-DsRed* transgenic silkworms; **B.** *OpIE2-BmAgo2* transgenic silkworms; **C and D.** qRT-PCR quantification of the *DsRed* gene transcription level of *IE1-DsRed* and *OpIE2-BmAgo2*transgenic silkworms after dsRNA treatment. Three independent biological replicates were used for the analysis. Error bars are means ± S.E.M.](ijbsv11p0176g005){#F5}

![**Enhancement of shRNA-mediated larval RNAi in *OpIE2-BmAgo2* transgenic silkworms. A.** Offspring resulting from crossing the *OpIE2-BmAgo2* and the *U6-Blos2 shRNA* transgenic silkworms. Siblings that expressed only the*BmBlos2*shRNA (Blos2^-^) and that co-expressed the *BmAgo2* and *BmBlos2* shRNA (Ago2^+^Blos2^-^) presented an oily skin phenotype (OSP). **B.**Quantification of the relative expression level of*BmBlos2* by qRT-PCR. The asterisks indicate statistical significance (*p*\<0.05), and error bars are means ± S.E.M.](ijbsv11p0176g006){#F6}

###### 

SiRNA interacting proteins in*B. mori*embryos identified by using MALDI-TOF/TOF analysis.

  Pro Name                              Accession NO.   Score   Sequence coverage (%)   Peptides matched   pI/MW(Exp.)
  ------------------------------------- --------------- ------- ----------------------- ------------------ ---------------
  BmHSP70                               gi\|320526705   180     14.33%                  8                  5.33/71359.3
  BmHSP70B                              gi\|336454474   145     4.5%                    2                  5.47/70712.9
  Cellular Retinoic Acid Binding Acid   gi\|108793850   85      16.54%                  2                  5.66/14963.4
  BmEnolase                             gi\|119381542   66      8.08%                   4                  5.62/47164.3
  BmAgo2                                gi\|166706854   8       4.82%                   5                  9.44/117243.8
  BmDicer2                              gi\|302318907   17      7.45%                   11                 6.15/192070.2
  BmTudor-sn                            gi\|302190081   20      9.68%                   8                  8.56/99418

###### 

Fluorescence investigation after dsRNA injection at day one of third larval instar. For each group, 25 larvae were subjected to injection. Non-injection and *EGFP* dsRNA injected animals were used as the control. Red fluorescence was investigated at 24h and 48 h after treatment.

  Transgenic lines   DsRNA for target genes   No. of larvae injected   No. of larvae showed fluorescence decrease          
  ------------------ ------------------------ ------------------------ -------------------------------------------- ------ ------
                                                                       0 h                                          24 h   48 h
  IE1-DsRed          Non-injection            25                       0                                            0      0
  *EGFP*             25                       0                        0                                            0      
  *DsRed*            25                       0                        1                                            0      
  OpIE2-BmAgo2       Non-injection            25                       0                                            1      0
  *EGFP*             25                       0                        3                                            1      
  *DsRed*            25                       0                        18                                           4      

###### 

Numbers of the animals which presented OSP in different transgenic lines.

  Genotype          No. of total animals   No. of OSP animals   Ratio of OSP animals
  ----------------- ---------------------- -------------------- ----------------------
  Ago2^+^           50                     0                    0
  Blos2^-^          97                     28                   28.9%
  Ago2^+^Blos2^-^   56                     36                   64.3%
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